mIDH1-IN-2
mIDH1-IN-2 is a brain-penetrant isocitrate dehydrogenase 1 (IDH1) inhibitor. mIDH1-IN-2 shows subnanomolar potency against IDH1 R132H and R132C (IC50 = 80.0 and 58.0 nM) and minimal activity against wt-IDH1/2. mIDH1-IN-2 also inhibits PDK1 (IC50 = 0.61 μM) and reduces PDH phosphorylation dose-dependently. mIDH1-IN-2 can inhibit cells proliferation, induces S phase arrest and promotes apoptosis. mIDH1-IN-2 can be used for the research of cancer, such as glioma.
For research use only. We do not sell to patients.
- Formula: C18H15Br2NO4S
- Molecular Weight:501.19
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
R132H IDH1 80 nM (IC50) |
R132C IDH1 58 nM (IC50) |
mIDH1-IN-2 (Compound 27j) inhibits HT1080 and U87-MG cells proliferation all profile with EC50 values of 121.1 nM and 69.0 nM, respectively[1].
mIDH1-IN-2 (1-5 μM, 24-48 h) induces S phase arrest and apoptosis in U87-MG IDH1 R132H cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:U87-MG IDH1 R132H cells
-
Concentration:1, 2 and 5 μM
-
Incubation Time:24 and 48 h
-
Result:Increased the proportion of apoptotic cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 501.19
-
Formula C18H15Br2NO4S
-
SMILES
O=C(C1=CC=C(SC2=CC=CC(OC3CCC3)=C2)C([N+]([O-])=O)=C1)C(Br)Br
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)